| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |